Warning! The directory is not yet complete and will be amended until the beginning of the term.
301908 VO Development of novel cancer immunotherapies (2025S)
from target identification through target validation to clinical trials
Labels
Registration/Deregistration
Note: The time of your registration within the registration period has no effect on the allocation of places (no first come, first served).
Details
Language: English
Lecturers
Classes
-digitale Lehre-
blocked., starts in april
more information follows
Information
Aims, contents and method of the course
The aim of the lecture is to transport the basic molecular, cellular and technological knowledge that is important for our understanding of current resistance mechanisms occurring in current immunotherapies. In Part II I will discuss state of the art methods which are currently employed to enhance our understanding of these mechanisms at play.
Assessment and permitted materials
Written exam, alternative: presentation
Minimum requirements and assessment criteria
Understanding of the basic mechanisms of resistance development and of newest technologies
Examination topics
Reading list
Association in the course directory
MMEI II-3.2, MMEI III, M-WZB, MMB IV., MNEU V., MES5
Last modified: Fr 17.01.2025 12:26